Disseminated intravascular coagulation physical examination: Difference between revisions
m (Categories) |
|||
Line 9: | Line 9: | ||
==References== | ==References== | ||
{{reflist|2}} | |||
{{ | [[Category:Hematology]] | ||
[[Category:Cardiology]] | |||
[[Category:Infectious disease]] | |||
{{WS}} | |||
{{WH}} | {{WH}} | ||
Revision as of 20:18, 16 June 2016
Disseminated intravascular coagulation Microchapters |
Differentiating Disseminated intravascular coagulation from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Disseminated intravascular coagulation physical examination On the Web |
American Roentgen Ray Society Images of Disseminated intravascular coagulation physical examination |
FDA on Disseminated intravascular coagulation physical examination |
CDC on Disseminated intravascular coagulation physical examination |
Disseminated intravascular coagulation physical examination in the news |
Blogs on Disseminated intravascular coagulation physical examination |
Directions to Hospitals Treating Disseminated intravascular coagulation |
Risk calculators and risk factors for Disseminated intravascular coagulation physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Physical examination
- More specific signs include petechiae, purpura, hemorrhagic bullae, acral cyanosis and occasionally frank gangrene.
- Microvascular thrombi are most often seen in the cardiac, pulmonary, renal, hepatic and CNS (central nervous system) circulation.